Dr. Awada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3031 W Grand Blvd
Detroit, MI 48202Phone+1 313-916-2464
Education & Training
George Washington UniversityResidency, Obstetrics and Gynecology, 2010 - 2014
American University of Beirut Faculty of MedicineClass of 2009
Certifications & Licensure
MI State Medical License 2024 - 2027
FL State Medical License 2021 - 2025
NY State Medical License 2018 - 2021
PA State Medical License 2014 - 2021
VA State Medical License 2010 - 2014
DC State Medical License 2010 - 2012- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Clinical Trials
- EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients Start of enrollment: 2007 Jan 01
- Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx Start of enrollment: 2007 May 01
- A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour Start of enrollment: 2008 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 118 citationsThe oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics.Ahmad Awada, Fatima Cardoso, Christel Fontaine, Luc Dirix, Jacques De Greve
European Journal of Cancer. 2008-01-01 - 174 citationsPlasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancerFrançoise Rothé, J-F Laes, Diether Lambrechts, Dominiek Smeets, Delphine Vincent
Annals of Oncology. 2014-10-01 - 350 citationsMONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer.Stephen R. D. Johnston, Miguel Martin, Angelo Di Leo, Seock-Ah Im, Ahmad Awada
NPJ Breast Cancer. 2019-01-17
Press Mentions
PharmaMar Announces Data Presentations for Both Its Molecules Yondelis® and Lurbinectedin at ASCO 2018August 3rd, 2018
‘Fighting My Cancer as Much as Possible’: Why Many Patients Join Phase 1 Clinical TrialsMarch 8th, 2018
Neratinib plus Paclitaxel vs. Trastuzumab plus Paclitaxel in Breast CancerApril 14th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
